← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. PNTG
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

PNTG logoThe Pennant Group, Inc. (PNTG) P/E Ratio History

Historical price-to-earnings valuation from 2019 to 2026

Current P/E
42.5
Undervalued
5Y Avg P/E
84.5
-50% vs avg
PE Percentile
55%
Average
PEG Ratio
4.23
Expensive
TTM EPS$0.85
Price$35.73
5Y PE Range26.3 - 378.5
Earnings Yield2.35%

Loading P/E history...

PNTG Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
42.5vs84.5
-50%
Cheap vs History
vs. Healthcare
42.5vs22.3
+91%
Above Sector
vs. S&P 500
42.5vs25.1
+69%
Above Market
PEG Analysis
4.23
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 18% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, The Pennant Group, Inc. (PNTG) trades at a price-to-earnings ratio of 42.5x, with a stock price of $35.73 and trailing twelve-month earnings per share of $0.85.

The current P/E is 50% below its 5-year average of 84.5x. Over the past five years, PNTG's P/E has ranged from a low of 26.3x to a high of 378.5x, placing the current valuation at the 55th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, PNTG trades at a 91% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

The PEG ratio of 4.23 (P/E divided by 18% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, PNTG commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PNTG DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PNTG P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ADUS logoADUSAddus HomeCare Corporation
$2B18.70.93Best+23%
ENSG logoENSGThe Ensign Group, Inc.
$10B29.82.16+14%
NVST logoNVSTEnvista Holdings Corp
$4B86.758.08+104%
NHC logoNHCNational HealthCare Corporation
$3B22.30.97+17%
OPCH logoOPCHOption Care Health, Inc.
$3B16.3-+3%
HCSG logoHCSGHealthcare Services Group, Inc.
$2B27.5-+53%
AVAH logoAVAHAveanna Healthcare Holdings Inc.
$1B6.6Lowest-+1952%Best
UNH logoUNHUnitedHealth Group Incorporated
$336B27.9--15%
HUM logoHUMHumana Inc.
$30B25.1--1%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

PNTG Historical P/E Data (2019–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1$30.48$0.8535.9x-65%
FY2025 Q4Wed Dec 31 2025 00:00:00 GM$28.15$0.8333.9x-67%
FY2025 Q3$25.22$0.7533.6x-67%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$29.85$0.7838.3x-63%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$25.15$0.7633.1x-68%
FY2024 Q4$26.52$0.7037.9x-63%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$35.70$0.6852.5x-49%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$23.19$0.6336.8x-64%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$19.63$0.5436.2x-65%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$13.92$0.4431.4x-69%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$11.13$0.4226.3x-74%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$12.28$0.4328.3x-72%

Average P/E for displayed period: 102.4x

See PNTG's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is PNTG Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare PNTG vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

PNTG — Frequently Asked Questions

Quick answers to the most common questions about buying PNTG stock.

Is PNTG stock overvalued or undervalued?

PNTG trades at 42.5x P/E, below its 5-year average of 84.5x. At the 55th percentile of historical range, the stock is priced at a discount to its own history.

How does PNTG's valuation compare to peers?

The Pennant Group, Inc. P/E of 42.5x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is PNTG's PEG ratio?

PNTG PEG ratio is 4.23. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2019-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

PNTG P/E Ratio History (2019–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.